1. Pink Sheet
  2. >>Geography
  3. >>Europe

Guido Rasi - The Face Of The EMA For A Decade

Executive Director To Leave Agency Later This Year

 
• By Ian Schofield and Maureen Kenny

The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.  

Pink Sheet Perspectives 2019 to 2020

Holders of the top job at the European Medicines Agency tend to stay in the post for a long time. Guido Rasi, the current executive director and only the third in the 25-year history of the EMA, is no exception. When he steps down towards the end of this year, he will have been in the top job for most of the past decade.

Rasi, a university professor and former head of the Italian medicines regulator, AIFA, first took up the reins in November 2011 – supposedly for a five-year tenure. However, after three...

More from Europe

More from Geography

How Pharma Companies Can Mitigate The Impact Of US Tariffs On The Supply Chain

 
• By Ewan Townsend

If US tariffs on pharmaceutical supply chain products come into force they could be disruptive for companies. Ewan Townsend, of the international law firm Arnold & Porter, explains how companies can mitigate issues through negotiating with suppliers and reallocating tariff responsibilities.

Japan Price Cuts For Epkinly and Lunsumio Following CEA

 
• By Lisa Takagi

Japan is cutting more drug reimbursement prices following cost effectiveness analysis and is applying the methodology to a new group of products including Wegovy and Leqembi.